|
MAD2L1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.22469999697117E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.57052999999463E-05 |
| Normal-vs-Stage2 |
7.377200E-04 |
| Normal-vs-Stage3 |
3.81110000000628E-05 |
| Normal-vs-Stage4 |
1.12439999999658E-06 |
| Stage1-vs-Stage2 |
9.657000E-01 |
| Stage1-vs-Stage3 |
6.296000E-01 |
| Stage1-vs-Stage4 |
9.884200E-03 |
| Stage2-vs-Stage3 |
7.717000E-01 |
| Stage2-vs-Stage4 |
2.642100E-02 |
| Stage3-vs-Stage4 |
3.366000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.9016000147617E-09 |
| Normal-vs-AfricanAmerican |
1.941590E-02 |
| Normal-vs-Asian |
3.042200E-01 |
| Caucasian-vs-AfricanAmerican |
1.761050E-03 |
| Caucasian-vs-Asian |
7.110400E-01 |
| AfricanAmerican-vs-Asian |
4.697800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.03649999694255E-08 |
| Normal-vs-Female |
1.50023999999638E-05 |
| Male-vs-Female |
3.679400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.981400E-03 |
| Normal-vs-Age(41-60Yrs) |
3.03079999985911E-07 |
| Normal-vs-Age(61-80Yrs) |
8.96459999566446E-08 |
| Normal-vs-Age(81-100Yrs) |
1.681890E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.371600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.876800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.352400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.252000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.926400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.152200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.530950E-01 |
| Normal-vs-Grade 2 |
1.01480000003207E-06 |
| Normal-vs-Grade 3 |
1.67949999996253E-06 |
| Normal-vs-Grade 4 |
1.72013999999443E-05 |
| Grade 1-vs-Grade 2 |
9.398500E-03 |
| Grade 1-vs-Grade 3 |
1.419760E-02 |
| Grade 1-vs-Grade 4 |
4.750300E-04 |
| Grade 2-vs-Grade 3 |
7.226200E-01 |
| Grade 2-vs-Grade 4 |
2.122400E-02 |
| Grade 3-vs-Grade 4 |
1.405860E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.363000E-04 |
| Normal-vs-ccB subtype |
9.74729996716661E-09 |
| ccA subtype-vs-ccB subtype |
5.157400E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.99090000438684E-08 |
| Normal-vs-N1 |
2.599600E-03 |
| N0-vs-N1 |
4.892200E-02 |
|
|
